Cargando…
Gastroduodenal Mucosal Injury in Patients Taking Low-Dose Aspirin and the Role of Gastric Mucoprotective Drugs: Possible Effect of Rebamipide
The present study was conducted to investigate the prevalence of mucosal injury in patients taking low-dose aspirin in Japan and examine the effect of gastric mucoprotective drugs on aspirin-related gastroduodenal toxicity. We selected 530 patients who had taken low-dose aspirin for 1 month or more...
Autores principales: | Yamamoto, Takatsugu, Isono, Akari, Mishina, Yuji, Ebato, Tadahisa, Shirai, Tsuguru, Nakayama, Shin, Nagasawa, Kunitaka, Abe, Koichiro, Hattori, Kengo, Ishii, Taro, Kuyama, Yasushi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
the Society for Free Radical Research Japan
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901760/ https://www.ncbi.nlm.nih.gov/pubmed/20664727 http://dx.doi.org/10.3164/jcbn.09-103 |
Ejemplares similares
-
Determination of the adequate dosage of rebamipide, a gastric mucoprotective drug, to prevent low-dose aspirin-induced gastrointestinal mucosal injury
por: Ota, Kazuhiro, et al.
Publicado: (2016) -
Rebamipide, a mucoprotective drug, inhibits NSAIDs-induced gastric mucosal injury: possible involvement of the downregulation of 15-hydroxyprostaglandin dehydrogenase
por: Tanigawa, Tetsuya, et al.
Publicado: (2011) -
Efficacy of rebamipide for low-dose aspirin-related gastrointestinal symptoms
por: Mizukami, Kazuhiro, et al.
Publicado: (2012) -
Metronidazole-Induced Neurotoxicity Developed in Liver Cirrhosis
por: Yamamoto, Takatsugu, et al.
Publicado: (2012) -
Severe Erosive Esophagitis Developing After Gastric Ulcer Formation
por: Yamamoto, Takatsugu, et al.
Publicado: (2012)